News | January 31, 2022
Sun Pharma Q3FY22 PAT at Rs 2058.8 cr.
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
The aim is to strengthen industry-academia cooperation
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The company has been manufacturing masks since the Covid-19 outbreak in 2020
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
Narayanan to lead SeQuent through next phase of consolidation and growth
The company’s platform technology works like a compression algorithm for molecular testing and has applications in healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research
He has over 29 years of experience in the field of manufacturing, R&D, business and customer service management
Tangent offers ISO/IEC 17025-accredited calibrations and has labs located in both Indianapolis and Huntsville, Alabama
In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc
Subscribe To Our Newsletter & Stay Updated
